DrugPatentWatch Database Preview
Drugs in Development Information for Laquinimod
Development status for investigational drug Laquinimod: Patents, clinical trial progress, indications
Laquinimod is an investigational drug.
There have been 15 clinical trials for Laquinimod.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2014.
The most common disease conditions in clinical trials are Multiple Sclerosis, Sclerosis, and Multiple Sclerosis, Relapsing-Remitting. The leading clinical trial sponsors are Teva Pharmaceutical Industries, Teva Branded Pharmaceutical Products, R&D Inc., and [disabled in preview].
Summary for Laquinimod
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 644 |
| WIPO Patent Applications | 397 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2014-01-01) |
| Vendors | 84 |
Recent Clinical Trials for Laquinimod
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo | Teva Pharmaceutical Industries | Phase 2 |
| A Clinical Study in Subjects With Huntington's Disease to Assess the Efficacy and Safety of Three Oral Doses of Laquinimod | Teva Branded Pharmaceutical Products, R&D Inc. | Phase 2 |
| A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given Together | Teva Pharmaceutical Industries | Phase 1 |
Clinical Trial Summary for Laquinimod
Top disease conditions for Laquinimod
Top clinical trial sponsors for Laquinimod
US Patents for Laquinimod
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
